Private company

Carisma Therapeutics Inc.

Last updated Oct 16, 2026.

Overview

  • IndustryPharmaceutical Preparations
  • HeadquartersDE
  • Incorporated inDE2
  • Business address3675 Market Street, Suite 401, Philadelphia, Pa 191042
  • Filer categoryNon-accelerated filer, Smaller reporting company2

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2024

-317.2%Operating margin3
-308.6%Net margin3
31.5%Revenue growth, 20243
-$60.0MFree cash flow3

Where the money goes

Where each dollar of revenue went, fiscal 2024

  • Research and development100¢$59.7M

Out of $19.6M in revenue.3 The company lost money this year.

Financial statements

Revenue45673$19.6M in 2024
0$10.0M$20.0M$30.0M2018: $0$020182019: $0$020192020: $11.2M$11.2M20202021: $26.5M$26.5M2021+136%2022: $9.8M$9.8M2022−63%2023: $14.9M$14.9M2023+52%2024: $19.6M$19.6M2024+32%
Operating income45673-$62.2M in 2024+80% since 2018
-$150.0M-$100.0M-$50.0M02018: -$34.5M-$34.5M20182019: -$108.5M-$108.5M2019+214%2020: -$21.1M-$21.1M2020−81%2021: -$8.5M-$8.5M2021−59%2022: -$56.2M-$56.2M2022+557%2023: -$88.7M-$88.7M2023+58%2024: -$62.2M-$62.2M2024−30%
Net income45673-$60.5M in 2024+79% since 2018
-$150.0M-$100.0M-$50.0M02018: -$33.7M-$33.7M20182019: -$107.5M-$107.5M2019+219%2020: -$22.4M-$22.4M2020−79%2021: -$336.0K-$336.0K2021−98%2022: -$61.2M-$61.2M2022+18122%2023: -$86.9M-$86.9M2023+42%2024: -$60.5M-$60.5M2024−30%
Fiscal year2018201920202021202220232024
Revenue$04$05$11.2M6$26.5M6$9.8M7$14.9M3$19.6M3
Research and development$14.1M4$24.7M5$29.2M6$25.3M6$56.6M7$74.1M3$59.7M3
Operating income-$34.5M4-$108.5M5-$21.1M6-$8.5M6-$56.2M7-$88.7M3-$62.2M3
Income tax$04$05$1.4M6-$8.3M6-$3.9M6
Net income-$33.7M4-$107.5M5-$22.4M6-$336.0K6-$61.2M7-$86.9M3-$60.5M3
Earnings per share-$0.5510-$1.185-$0.196$0.006-$28.777-$2.593-$1.463
Earnings per share (diluted)-$0.5510-$1.185-$0.196$0.006-$28.777-$2.593-$1.463

Compare Carisma Therapeutics Inc. with another company

Former names

  • Sesen Bio, Inc.Apr 2, 2018 to Mar 6, 20232
  • Eleven Biotherapeutics, Inc.Feb 24, 2010 to May 16, 20182

Recent filings

  1. Dec 5, 20258-K
  2. Nov 12, 202510-Q
  3. Oct 15, 20258-K
  4. Oct 9, 20258-K
  5. Oct 8, 20254 OWNERSHIP DOCUMENT
  6. Oct 3, 20254 OWNERSHIP DOCUMENT
  7. Sep 18, 20258-K
  8. Aug 29, 20258-K
  9. Aug 8, 20258-K
  10. Aug 7, 202510-Q
  11. Jul 15, 20258-K
  12. Jul 7, 2025DEF 14A
  13. Jun 23, 20258-K
  14. Jun 12, 20258-K
  15. May 13, 202510-Q

Every filing from the last three years, summarized. The full record is on SEC EDGAR.1

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11